A-Life Medical selected as Finalist for Crimson Herrings North America 100 award A-Life Medical.

Now, we’re confronted with the trial of selecting the Top 100 winners of the Red Herring THE UNITED STATES award. We understand that this year’s crop will grow into some amazing businesses that will definitely go considerably. Finalists for the 2010 edition of the Red Herring 100 THE UNITED STATES award are selected based upon their know-how, management strength, marketplace size, investor record, client acquisition, and financial health. Through the several months before the announcement, a huge selection of businesses in the telecommunications, security, Blogging platforms 2.0, software, equipment, biotech, and clean tech sectors sent in their submissions to qualify for the award.As of September 30, 2009 Acorda held cash, money equivalents, and short-term investments of $292.4 million. The ongoing business expects this balance provides a year-end 2009 cash, money equivalents and short-term investment balance more than $250 million. On October 14 Fampridine-SR Update, the Peripheral and Central Nervous System Medicines Advisory Committee appointed by the FDA voted 12 to 1 1 that clinical data on Fampridine-SR 10 mg twice daily demonstrated considerable evidence of effectiveness as cure to improve walking in people who have multiple sclerosis and voted 10 to 2 that it’s clinically meaningful and will be safe for make use of.